Prevalence of non-falciparum malaria infections among asymptomatic individuals in four regions of Mainland Tanzania.

Plasmodium malariae Plasmodium ovale Plasmodium vivax Asymptomatic malaria Malaria Non-falciparum species Tanzania

Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
23 Mar 2024
Historique:
received: 29 12 2023
accepted: 11 03 2024
medline: 23 3 2024
pubmed: 23 3 2024
entrez: 23 3 2024
Statut: epublish

Résumé

Recent studies point to the need to incorporate the detection of non-falciparum species into malaria surveillance activities in sub-Saharan Africa, where 95% of the world's malaria cases occur. Although malaria caused by infection with Plasmodium falciparum is typically more severe than malaria caused by the non-falciparum Plasmodium species P. malariae, P. ovale spp. and P. vivax, the latter may be more challenging to diagnose, treat, control and ultimately eliminate. The prevalence of non-falciparum species throughout sub-Saharan Africa is poorly defined. Tanzania has geographical heterogeneity in transmission levels but an overall high malaria burden. To estimate the prevalence of malaria species in Mainland Tanzania, we randomly selected 1428 samples from 6005 asymptomatic isolates collected in previous cross-sectional community surveys across four regions and analyzed these by quantitative PCR to detect and identify the Plasmodium species. Plasmodium falciparum was the most prevalent species in all samples, with P. malariae and P. ovale spp. detected at a lower prevalence (< 5%) in all four regions; P. vivax was not detected in any sample. The results of this study indicate that malaria elimination efforts in Tanzania will need to account for and enhance surveillance of these non-falciparum species.

Sections du résumé

BACKGROUND BACKGROUND
Recent studies point to the need to incorporate the detection of non-falciparum species into malaria surveillance activities in sub-Saharan Africa, where 95% of the world's malaria cases occur. Although malaria caused by infection with Plasmodium falciparum is typically more severe than malaria caused by the non-falciparum Plasmodium species P. malariae, P. ovale spp. and P. vivax, the latter may be more challenging to diagnose, treat, control and ultimately eliminate. The prevalence of non-falciparum species throughout sub-Saharan Africa is poorly defined. Tanzania has geographical heterogeneity in transmission levels but an overall high malaria burden.
METHODS METHODS
To estimate the prevalence of malaria species in Mainland Tanzania, we randomly selected 1428 samples from 6005 asymptomatic isolates collected in previous cross-sectional community surveys across four regions and analyzed these by quantitative PCR to detect and identify the Plasmodium species.
RESULTS RESULTS
Plasmodium falciparum was the most prevalent species in all samples, with P. malariae and P. ovale spp. detected at a lower prevalence (< 5%) in all four regions; P. vivax was not detected in any sample.
CONCLUSIONS CONCLUSIONS
The results of this study indicate that malaria elimination efforts in Tanzania will need to account for and enhance surveillance of these non-falciparum species.

Identifiants

pubmed: 38519992
doi: 10.1186/s13071-024-06242-4
pii: 10.1186/s13071-024-06242-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153

Subventions

Organisme : NIH HHS
ID : K24AI134990
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

WHO. World malaria report 2022. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022 . Accessed 24 Mar 2023
Akala HM, Watson OJ, Mitei KK, Juma DW, Verity R, Ingasia LA, et al. Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study. Lancet Microbe. 2021;2:e141–50.
doi: 10.1016/S2666-5247(21)00009-4 pubmed: 35544189 pmcid: 7613221
Betson M, Clifford S, Stanton M, Kabatereine NB, Stothard JR. Emergence of nonfalciparum Plasmodium infection despite regular artemisinin combination therapy in an 18-month longitudinal study of Ugandan children and their mothers. J Infect Dis. 2018;217:1099–109.
doi: 10.1093/infdis/jix686 pubmed: 29325068 pmcid: 5939692
Yman V, Wandell G, Mutemi DD, Miglar A, Asghar M, Hammar U, et al. Persistent transmission of Plasmodium malariae and Plasmodium ovale species in an area of declining Plasmodium falciparum transmission in eastern Tanzania. PLOS Negl Trop Dis. 2019;13:e0007414.
doi: 10.1371/journal.pntd.0007414 pubmed: 31136585 pmcid: 6555537
Nguiffo-Nguete D, Nongley Nkemngo F, Ndo C, Agbor J-P, Boussougou-Sambe ST, Salako Djogbénou L, et al. Plasmodium malariae contributes to high levels of malaria transmission in a forest–savannah transition area in Cameroon. Parasit Vectors. 2023;16:1–10.
doi: 10.1186/s13071-022-05635-7
Sendor R, Mitchell CL, Chacky F, Mohamed A, Mhamilawa LE, Molteni F, et al. Similar prevalence of Plasmodium falciparum and non-P falciparum malaria infections among Schoolchildren, Tanzania. Emerg Infect Dis. 2023;29:1143–53.
doi: 10.3201/eid2906.221016 pubmed: 37209670 pmcid: 10202886
WHO. Global technical strategy for malaria 2016–2030. 2015. https://www.who.int/docs/default-source/documents/global-technical-strategy-for-malaria-2016-2030.pdf . Accessed 16 Jul 2021
Tarimo BB, Nyasembe VO, Ngasala B, Basham C, Rutagi IJ, Muller M, et al. Seasonality and transmissibility of Plasmodium ovale in Bagamoyo district, Tanzania. Parasit Vectors. 2022;15:56.
doi: 10.1186/s13071-022-05181-2 pubmed: 35164867 pmcid: 8842944
Collins WE, Jeffery GM. Plasmodium ovale: parasite and disease. Clin Microbiol Rev. 2005;18:570–81.
doi: 10.1128/CMR.18.3.570-581.2005 pubmed: 16020691 pmcid: 1195966
Oriero EC, Amenga-Etego L, Ishengoma DS, Amambua-Ngwa A. Plasmodium malariae, current knowledge and future research opportunities on a neglected malaria parasite species. Crit Rev Microbiol. 2021;0:1–13.
Roucher C, Rogier C, Sokhna C, Tall A, Trape JF. A 20-year longitudinal study of Plasmodium ovale and Plasmodium malariae prevalence and morbidity in a West African population. PLoS ONE. 2014;9:e87169.
doi: 10.1371/journal.pone.0087169 pubmed: 24520325 pmcid: 3919715
Popkin-Hall ZR, Seth MD, Madebe RA, Budodo R, Bakari C, Francis F, et al. Malaria species positivity rates among symptomatic individuals across regions of differing transmission intensities in Mainland Tanzania. J Infect Dis. 2023. https://doi.org/10.1093/infdis/jiad522 .
doi: 10.1093/infdis/jiad522 pubmed: 37992117
Rogier E, Battle N, Bakari C, Seth MD, Nace D, Herman C, et al. Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021. medRxiv. 2023;223:S81.
Emerson C, Ulimboka S, Lemwayi R, Kinyina A, Nhiga SL, Aaron S, et al. Women attending antenatal care as a sentinel surveillance population for malaria in Geita region, Tanzania: feasibility and acceptability to women and providers. Malar J. 2023;22:1–10.
doi: 10.1186/s12936-023-04480-y
Gutman JR, Mwesigwa JN, Arnett K, Kangale C, Aaron S, Babarinde D, et al. Using antenatal care as a platform for malaria surveillance data collection: study protocol. Malar J. 2023;22:1–10.
doi: 10.1186/s12936-023-04521-6
Massicotte P, South A. rnaturalearth: world map data from natural earth. 2023. https://cran.r-project.org/web/packages/rnaturalearth/index.html . Accessed 7 Aug 2023
Abdulraheem MA, Ernest M, Ugwuanyi I, Abkallo HM, Nishikawa S, Adeleke M, et al. High prevalence of Plasmodium malariae and Plasmodium ovale in co-infections with Plasmodium falciparum in asymptomatic malaria parasite carriers in southwestern Nigeria. Int J Parasitol. 2022;52:23–33.
doi: 10.1016/j.ijpara.2021.06.003 pubmed: 34390743
Andolina C, Rek JC, Briggs J, Okoth J, Musiime A, Ramjith J, et al. Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study. Lancet Infect Dis. 2021;21:1568–78.
doi: 10.1016/S1473-3099(21)00072-4 pubmed: 34146476 pmcid: 8554388
Walldorf JA, Cohee LM, Coalson JE, Bauleni A, Nkanaunena K, Kapito-Tembo A, et al. School-age children are a reservoir of malaria infection in Malawi. PLoS ONE. 2015;10:e0134061.
doi: 10.1371/journal.pone.0134061 pubmed: 26207758 pmcid: 4514805
Liu Q, Yan W, Qin C, Du M, Liu M, Liu J. Millions of excess cases and thousands of excess deaths of malaria occurred globally in 2020 during the COVID-19 pandemic. J Glob Health. 2022;12:05045.
doi: 10.7189/jogh.12.05045 pubmed: 36527272 pmcid: 9757497

Auteurs

Zachary R Popkin-Hall (ZR)

Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA. zach_popkin-hall@med.unc.edu.

Misago D Seth (MD)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Rashid A Madebe (RA)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Rule Budodo (R)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Catherine Bakari (C)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Filbert Francis (F)

National Institute for Medical Research, Tanga Center, Tanga, Tanzania.

Dativa Pereus (D)

National Institute for Medical Research, Dar es Salaam, Tanzania.

David J Giesbrecht (DJ)

The Connecticut Agricultural Experiment Station, New Haven, CT, USA.

Celine I Mandara (CI)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Daniel Mbwambo (D)

National Malaria Control Programme, Dodoma, Tanzania.

Sijenunu Aaron (S)

National Malaria Control Programme, Dodoma, Tanzania.

Abdallah Lusasi (A)

National Malaria Control Programme, Dodoma, Tanzania.

Samwel Lazaro (S)

National Malaria Control Programme, Dodoma, Tanzania.

Jeffrey A Bailey (JA)

Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.
Center for Computational Molecular Biology, Brown University, Providence, RI, USA.

Jonathan J Juliano (JJ)

Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.

Julie R Gutman (JR)

Malaria Branch, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.

Deus S Ishengoma (DS)

National Institute for Medical Research, Dar es Salaam, Tanzania.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Faculty of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.

Classifications MeSH